Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.
Connolly
K J
KJ
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts.
Hammer
S M
SM
D000917:Antibody Formation / Q000187:drug effects; D000998:Antiviral Agents / Q000276:immunology / Q000627:therapeutic use*; D015694:Gene Products, rev / Q000037:antagonists & inhibitors; D015696:Gene Products, tat / Q000037:antagonists & inhibitors; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors; D054321:rev Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus
D000998:Antiviral Agents; D015694:Gene Products, rev; D015696:Gene Products, tat; D018894:Reverse Transcriptase Inhibitors; D054321:rev Gene Products, Human Immunodeficiency Virus; D054322:tat Gene Products, Human Immunodeficiency Virus